VBIO

Value Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Total revenue 180 K70 K86 K146 K—33 K — Gross profit -239 K50 K54 K-145 K—33 K — Operating expenses 1.24 M1.56 M1.99 M2.34 M2.19 M5.63 M 12.15 M Selling/general/admin expenses 911 K1.22 M1.33 M1.48 M149 K3.78 M 6.74 M Research & development 333 K335 K655 K858 K1.28 M1.85 M 4.65 M Operating income -1.48 M-1.51 M-1.93 M-2.48 M-2.1 M-5.63 M -12.15 M Non-Operating Income, Total 66 K4 0003 000-113 K11 K-591 K -690 K Interest expense, net of interest capitalized —————648 K — Non-Operating Income, excl. Interest Expenses 66 K4 0003 000-113 K11 K-1.24 M -1.34 M Unusual income/expense —————— — Pretax income -1.42 M-1.5 M-1.93 M-2.6 M8.9 M-6.87 M -2.5 M Equity in earnings —————— — Taxes ————0— — Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations -1.48 M-1.5 M-1.93 M-2.6 M-2.85 M-6.22 M -13.6 M Discontinued operations —————23 K — Net income -1.48 M-1.5 M-1.93 M-2.6 M-2.85 M-6.2 M -13.58 M Dilution adjustment —000—0 — Preferred dividends —01 00036 K—235 K — Diluted net income available to common stockholders -1.48 M-1.5 M-1.93 M-2.63 M-2.85 M-6.44 M -13.85 M Basic earnings per share (Basic EPS) 6.77-2.52-2.19-1.97-1.16-2.23 -7.55 Diluted earnings per share (Diluted EPS) 6.75-2.52-2.19-1.97-2.47-2.15 -8.77 Average basic shares outstanding 287.37 K596.37 K881.29 K1.32 M1.16 M2.88 M — Diluted shares outstanding 287.37 K596.37 K881.29 K1.32 M1.16 M2.88 M — EBITDA -1.48 M-1.5 M-1.93 M-2.48 M—-5.15 M — EBIT -1.48 M-1.51 M-1.93 M-2.48 M—-5.6 M — Cost of revenue 419 K20 K32 K291 K—— — Other cost of goods sold 338 K————— — Depreciation & amortization (cash flow) 01 0001 00003 000449 K 453 K